Jeremy Rowe

TL;DR: Minimal interference, maintenance of quality of life, and conservation of function or auditory rehabilitation are the cornerstones of NF2 management, and the decision points to achieve these goals for patients with different clinical presentations are discussed.

TL;DR: No increased risk of malignancy was detected in this series, supporting the safety of radiosurgery, and the risks of malignant transformation in benign tumors would seem small in the context of the other risks faced by patients with intracranial pathologies requiring radiosurgical treatments.

TL;DR: In this paper, a retrospective cohort study comparing the Sheffield, England, radiosurgery patient database with national mortality and cancer registries was conducted, showing that no increased risk of malignancy was detected in this series.

TL;DR: Radiosurgery is a valuable minimally invasive alternative treatment for these tumours, it controls growth or defers the need for surgery, or both, and there is a price in terms of hearing function, although this may compare favourably with the deafness associated with the natural history of the disease, and with surgery.

TL;DR: Tumour control rates, while difficult to define, are comparable after radiosur surgery with those experienced after surgery, which may make radiosurgery increasingly the treatment of choice for small and medium sized acoustic neuromas.